Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double‐Blind Placebo‐Controlled Pilot Multi‐Center Trial ( PRODG )
Journal of the American Geriatrics Society · 2026-07 · 74 (7) · 2021-2031
DOI: 10.1111/jgs.70530 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 17.06.2026. Verfasst von Preeti Sinha und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India. Hauptthemen laut MEDLINE: Probiotics, Antidepressive Agents, Depressive Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health Research, India.
Themen: Depression
Abstract (Originalsprache)
Objective
To evaluate the efficacy of adjunct probiotic supplementation ( Lactobacillus helveticus and Bifidobacterium longum ) alongside standard care compared to placebo in older adults with moderate unipolar depression.
Methods
A randomized, double‐blind, placebo‐controlled pilot trial was conducted at two tertiary centers. Fifty‐eight participants (≥ 60 years) with moderate depression were randomized 1:1 to receive daily probiotics or a placebo for 12 weeks, alongside standard antidepressant care. They were followed up for another 12 weeks. The primary outcome was depression response (≥ 50% Montgomery‐Åsberg Depression Rating Scale [MADRS] score reduction). Secondary outcomes included anxiety (General Anxiety Disorder 7‐Item [GAD‐7]), cognition, quality of life (WHOQOL‐BREF), serum brain‐derived neurotropic factor (BDNF), and gut microbiota profile.
Results
Mixed‐effects models showed significant improvement over time in depressive symptoms (MADRS: F = 32.0, p < 0.001) and anxiety (GAD‐7: F = 13.1, p < 0.001). Overall scores were lower in the probiotic group compared with the placebo group for both MADRS ( F = 12.7, p = 0.001) and GAD‐7 ( F = 10.7, p = 0.002), although group × time interactions were not significant. Quality‐of‐life domains improved markedly (all F > 100, p < 0.001) without additional benefit from probiotics. Escitalopram‐equivalent antidepressant dose and benzodiazepine use influenced selected outcomes. The probiotic group also had a significantly higher serum BDNF level and increased fecal abundance of supplemented strains vs. the placebo group. The attrition rate was > 50% over 24 weeks.
Conclusion
In this pilot PRODG trial, adjunct probiotics produced modest overall advantages for depressive and anxiety symptoms compared with placebo but did not enhance quality‐of‐life beyond usual improvement − both groups improved substantially, and trajectories over 24 weeks were largely parallel across follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
- Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India.
- Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
- Indian Council of Medical Research, New Delhi, India.
- Academy of Scientific and Innovative Research (An Institution of National Importance Established by an Act of Parliament), Ghaziabad, India.
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Abhinaba Ghosh, Saibal Das
Förderung
- Department of Health Research, India
Zitieren
APA
Sinha, P., Chatterjee, P., Kathiresan, P., Raju, K. S., Panwar, R., Mukherjee, A., Kumar, G., Cherian, J. J., Velayuthan, A., Chakrawarty, A., Mondal, S., Kalita, M., Kamboj, S., Sen, S., Bhattacharjee, M., Mondal, M., Bhowmik, K., Mukherjee, S., Saha, I., …, & Das, S. (2026). Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double‐Blind Placebo‐Controlled Pilot Multi‐Center Trial ( PRODG ). Journal of the American Geriatrics Society, 74(7), 2021-2031. https://doi.org/10.1111/jgs.70530
Vancouver
Sinha P, Chatterjee P, Kathiresan P, Raju KS, Panwar R, Mukherjee A, et al. Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double‐Blind Placebo‐Controlled Pilot Multi‐Center Trial ( PRODG ). Journal of the American Geriatrics Society. 2026;74(7):2021-2031. doi:10.1111/jgs.70530
BibTeX
@article{Sinha2026,
author = {Sinha, Preeti and Chatterjee, Prasun and Kathiresan, Preethy and Raju, Karishma Sundara and Panwar, Rasika and Mukherjee, Aparna and Kumar, Gunjan and Cherian, Jerin Jose and Velayuthan, Anoop and Chakrawarty, Avinash and Mondal, Sarnendu and Kalita, Manoj and Kamboj, Spriha and Sen, Sreyashi and Bhattacharjee, Mounamukhar and Mondal, Manaswini and Bhowmik, Kalyan and Mukherjee, Sovonlal and Saha, Indranil and Dutta, Atanu Kumar and Saha, Asim and Chakrabarti, Amit and Ghosh, Abhinaba and Das, Saibal},
title = {Efficacy of Adjunct PRObiotics as Compared to the Standard Care in Moderate Unipolar Depression Among Geriatric Patients: A Randomized Double‐Blind Placebo‐Controlled Pilot Multi‐Center Trial ( PRODG )},
journal = {Journal of the American Geriatrics Society},
year = {2026},
volume = {74},
number = {7},
pages = {2021--2031},
doi = {10.1111/jgs.70530}
}
EUVIMED